At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SITC SITE Centers Corp.
Trading 04-23 14:47:54 EDT
13.84
+0.09
+0.65%
High13.87Low13.67Vol647.52K
Open13.71D1 Closing13.75Amplitude1.45%
Mkt Cap2.68BTradable Cap2.12BTotal Shares193.59M
T/O8.95MT/O Rate0.42%Tradable Shares153.12M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Society for Immunotherapy of Cancer Publishes Recommendations on Optimal Intratumoral Immunotherapy Clinical Trial (IICT) Design
StreetInsider  ·  00:00
Society for Immunotherapy of Cancer Publishes Recommendations on Optimal Intratumoral Immunotherapy Clinical Trial (IICT) Design
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire  ·  04-22 21:10
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
SITC and the NCI Announce Fourth Year of Collaboration with the New AI in IO: Computational Immuno-oncology Webinar Series
StreetInsider  ·  04-12
SITC and the NCI Announce Fourth Year of Collaboration with the New AI in IO: Computational Immuno-oncology Webinar Series
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
GlobeNewswire  ·  04-09
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
GlobeNewswire  ·  04-04
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
Press Release: Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
Dow Jones  ·  04-02
Press Release: Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
Press Release: Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs
Dow Jones  ·  04-02
Press Release: Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs
SITE Centers (NYSE:SITC) Receives Overweight Rating from Wells Fargo & Company
Defense World  ·  04-02
SITE Centers (NYSE:SITC) Receives Overweight Rating from Wells Fargo & Company
Press Release: MaaT Pharma Announces 2023 Annual Results and Provides a Business Overview
Dow Jones  ·  03-29
Press Release: MaaT Pharma Announces 2023 Annual Results and Provides a Business Overview
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights
GlobeNewswire  ·  03-28
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights
Press Release: Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Dow Jones  ·  03-26
Press Release: Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
GlobeNewswire  ·  03-22
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
Press Release: Tempest Reports Year End 2023 Financial Results and Provides Business Update
Dow Jones  ·  03-20
Press Release: Tempest Reports Year End 2023 Financial Results and Provides Business Update
Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
GlobeNewswire  ·  03-14
Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023

Introduction

Company Name.
SITE Centers Corp.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
SITE Centers is an owner and manager of open-air shopping centers located in suburban, high household income communities. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC.
Issue price:
--